STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #710 by analyst upside · 2026-06-27
TSNDF
TerrAscend Corp.
Healthcare · Market Cap $254M · P/E 0x
ANALYST PRICE TARGET
+120.3%
implied upside to consensus target
Current Price $0.68
Consensus Target $1.5
Bull Target $1.5
Bear Target $1.5
Analysts Covering 1
ANALYST CONSENSUS — BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $0.25
52-Week High $1.45
YTD Return -11.3%
FUNDAMENTALS
Market Cap $254M
P/E Ratio (TTM) N/A
Forward P/E -19.5x
EPS (TTM) $-0.10
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $262M
Profit Margin -31.2%
52-WEEK RANGE
52-Week Low $0.25
52-Week High $1.45
Current Price $0.68
Bear Target $1.5
Bull Target $1.5
● Now $0.68 ● Target $1.5
TRADING DATA
Avg Volume 430K
YTD Return -11.3%
Analyst Count 1
Consensus Buy
Upside to Target +120.3%
Last Updated 2026-06-27

ANALYST SUMMARY

TerrAscend Corp. (TSNDF) is currently trading at $0.68 with a Wall Street consensus price target of $1.5, implying potential upside of 120.3% over the next 12 months. 1 analysts currently cover TSNDF, with a consensus rating of Buy — 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1.5, while the most cautious has a target of $1.5.

TSNDF operates in the Healthcare sector with a market capitalisation of $254M. The stock is down 11.3% year-to-date and is currently trading near the lower end of its 52-week range of $0.25 – $1.45.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →